Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study. Issue 2 (25th November 2022)

• Record Type: Journal Article
• Authors: Levi, Shai; Bronstein, Yotam; Goldschmidt, Neta; Morabito, Fortunato; Ziv‐Baran, Tomer; Del Poeta, Giovanni; Bairey, Osnat; Del Principe, Maria Ilaria; Fineman, Riva; Mauro, Francesca Romana; Gutwein, Odit; Reda, Gianluigi; Ruchlemer, Rosa; Sportoletti, Paolo; Laurenti, Luca; Shvidel, Lev; Coscia, Marta; Tadmor, Tamar; Varettoni, Marzia; Aviv, Ariel; Murru, Roberta; Braester, Andrei; Chiarenza, Annalisa; Visentin, Andrea; Pietrasanta, Daniela; Loseto, Giacomo; Zucchetto, Antonella; Bomben, Riccardo; Olivieri, Jacopo; Neri, Antonio; Rossi, Davide; Gaidano, Gianluca; Trentin, Livio; Foà, Robin; Cuneo, Antonio; Perry, Chava; Gattei, Valter; Gentile, Massimo; Herishanu, Yair;
• Is Part Of: American journal of hematology. Volume 98:Issue 2(2023)
• Page Start: E24
• Page End: E27
• Publication Date: 2022-11-25
• Subjects: Hematology -- Periodicals; 616.15
• DOI: 10.1002/ajh.26779
• Languages: English
• ISSNs: 0361-8609